20 results
Thumbnail

D3.51 - Cardiovascular System Problems in Children Athletes with Allergic Diseases

Thumbnail

D3.59 - Occupational Cobalt Contact Dermatitis: Clinical Profile and Work implications

Thumbnail

D3.52 - Clinical spectrum and diagnostic challenges of paediatric angioedema without wheals

Thumbnail

D3.55 - Hereditary angioedema with normal C1-INH: DAB2IP mutation report

Thumbnail

D3.56 - Investigation of Serum Eosinophilic Granule Proteins Levels in Children with Chronic Spontaneous Urticaria

Thumbnail

D3.58 - Eosinophilic ascites and extreme hypereosinophilia: differential diagnosis through medical treatment

Thumbnail

D3.60 - Allergic reaction in bisoprolol overdose

Thumbnail

D3.61 - Acquired Food Allergy After Allogeneic Hematopoietic Stem Cell Transplantation From a Non-Allergic Unrelated Donor

Thumbnail

D3.62 - Application of a logistic regression model to predict the risk of allergic reactions in children with salmon sensitization (Sal s 1)

Thumbnail

D3.50 - Molecular Characterization of Allergen Sensitization and Clinical Associations in a Romanian Cohort Using ALEX² Multiplex Assay

Thumbnail

D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region

Thumbnail

D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor

Thumbnail

D3.155 - Th2–Th17 immune shift following dupilumab therapy

Thumbnail

D3.160 - Study of the allergic sensitization profile in asthmatic patients consulting at ignace deen university hospital, conakry

Thumbnail

D3.164 - Early and Sustained Effect of Zumilokibart (APG777) in Atopic Dermatitis and Asthma: 16-Week Results from the Phase 2 APEX Study in Moderate-to-Severe AD and a Phase 1b Study in Mild-to-Moderate Asthma

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.447 - Pre-clinical Toxicology and Immunogenicity Evidence as a Precursor of the Successful Phase I/IIA Study with VLP Peanut

Thumbnail

D3.448 - Use of Sebetralstat as Short-term Prophylaxis for Patients with Hereditary Angioedema: Results from the KONFIDENT-S Study